R. A. Munteanu, “5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity”, Med Pharm Rep, vol. 97, no. 4, pp. 488–506, Sep. 2024.